Dr Jose M Ortiz Mercado, PHD | |
Carr. 402 Km 1.8, Anasco, PR 00610-0061 | |
(787) 209-1483 | |
Not Available |
Full Name | Dr Jose M Ortiz Mercado |
---|---|
Gender | Male |
Speciality | Psychologist - Counseling |
Location | Carr. 402 Km 1.8, Anasco, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871751909 | NPI | - | NPPES |
3018 | Other | PR | LICENCIA PERMANENTE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | 3018 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jose M Ortiz Mercado, PHD Po Box 993, Anasco, PR 00610-0993 Ph: (787) 209-1483 | Dr Jose M Ortiz Mercado, PHD Carr. 402 Km 1.8, Anasco, PR 00610-0061 Ph: (787) 209-1483 |
News Archive
Despite the knowledge that ethnicity matters in cardiovascular disease, most studies of cardiovascular disease risk have not been designed to yield results that apply to different ethnic groups, report Meghna Ranganathan and Raj Bhopal (of Edinburgh University) in a new study in the international open-access medical journal PLoS Medicine.
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
Small calf muscles may be a feminine trait, but for women with peripheral artery disease they're a major disadvantage. Researchers at Northwestern Medicine point to the smaller calf muscles of women as a gender difference that may cause women with PAD to experience problems walking and climbing stairs sooner and faster than men with the disease.
Palliative care-;which better aligns medical treatments with patients' goals and wishes, aggressively treats distressing symptoms, and improves care coordination, -;is associated with shorter hospital stays and lower costs, and shows its greatest effect among the sickest patients, according to a study published Monday, April 30, in JAMA Internal Medicine.
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
› Verified 8 days ago
Mr. Jonathan Muniz, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 60 Calle Daguey, Anasco, PR 00610 Phone: 787-229-1222 | |
Dr. Allary Villarrubia Soto, PH.D Psychologist Medicare: Medicare Enrolled Practice Location: Carr # 402 Km 2.1, Bo Marias, Anasco, PR 00610 Phone: 787-648-4486 | |
Migdalia Pousa, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Ave. Dr. Montalvo 10, Anasco, PR 00610 Phone: 787-826-1894 | |
Aracelys Astacio Ruiz, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: Valley Hills Professional Center, Local #5 Carr 402 Km 2.9, Anasco, PR 00610 Phone: 787-400-5484 | |
Miss Yadira Gomez, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: Carr 402 Km 1.8, Anasco, PR 00610 Phone: 787-464-3486 | |
Mrs. Yvonne I Mercer, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Carr. 4403 Km. 2.1 Int., Bo. Ajies, Anasco, PR 00610 Phone: 787-967-8515 | |
Mrs. Mirella Montalvo, M.S Psychologist Medicare: Not Enrolled in Medicare Practice Location: 60 Calle Daguey, Anasco, PR 00610 Phone: 787-229-1222 |